Back to articles

Revealed: Our Favorite Emerging Industry

This election season (like every election season) has been a wild one.

But our team was tracking results in Colorado very closely — and not for the reasons you might think.

We were tracking the legalization of psychedelics.

After passing by a slim margin, Proposition 122 will allow for the cultivation of psilocybin mushrooms and create state-regulated centers where Coloradans can make appointments to consume it.

Advocates for psilocybin tout the substance’s ability to treat mental health conditions such as depression and anxiety; and when taken in small enough doses, patients can achieve the desired health benefits without the “trippy” effects most people associate with “magic mushrooms.”

This method is called “microdosing” and is one of the fastest-growing trends in the LikeFolio universe, with mentions up 925% from last year.

Discussions surrounding the topic are exploding, and the sample size is nothing to scoff at. We logged more than 100,000 of these topical discussions last quarter alone.

Despite this surge in interest, this trend is still in the very early stages of development.

Colorado, after all, is only the second state (behind Oregon) to legalize access to psilocybin in this nature.

But as an investor, it’s something to watch.

This treatment could serve as a solution for those struggling with their mental health, which has become increasingly common post-pandemic.

According to the National Institute of Mental Health, as many as one in five American adults are living with a mental health disorder. And 1.5 million folks in Colorado alone are in need of treatment.

So, we’re beefing up our research in this segment and adding to our coverage list three major drug companies that specialize in the development of therapeutic psychedelic compounds.

These names are live on our research dashboard for ongoing tracking:

  • ATAI Life Sciences N.V. (ATAI)
  • COMPASS Pathways (CMPS)
  • Mind Medicine (MindMed) Inc. (MNMD)

While the world of psychedelic treatments is still in the early phases, it’s always better to be informed about potential investment opportunities.

Related content

Chip Shortage ‘Pin Action’

August 22, 2021Lisa Lenda

As an investor, I’m always on the lookout for the secondary effects of major trends. The “pin action.” The other day, I drove by the Kentucky Speedway in Sparta, Kentucky, and guess what I saw? Thousands and thousands of Ford F-150 trucks — brand new ones — as far as the eye could see. In fact, just a few weeks ago it was reported that there are more than 60,000 of these trucks stranded, waiting for the chips that make their

The Truth About Starbucks (SBUX)

December 12, 2021Lisa Lenda

Starbucks is in the news again. This time (unfortunately) it’s NOT because of Pumpkin Spice Lattes. This week, Starbucks workers voted to form their first U.S. union in a Buffalo, N.Y., store. For now we’re going to table the union discussion. Because that’s not where LikeFolio data can provide unique insight. Instead, let’s break down the second part of that headline… Mobile Orders are Overwhelming Starbucks Baristas The sheer quantity of Starbucks mobile orders has climbed so high that employees

This Company Is Solving Major Problems for Diabetics

April 2, 2022Lisa Lenda

Some of my favorite companies were born by solving a simple consumer problem. For example, I hate emails. Sometimes I just want to be able to go straight to the source. Chat through something casually. Keep it rolling! I am a product of the ’90s, when AOL Instant Messenger was king, so this tracks. When I discovered Slack, it changed my life. We use the messaging service at LikeFolio in lieu of old-school emails. We communicate directly and efficiently, and